Supplementary protection
LT - Pakeistieji 3,5-difenil-1,2,4-triazolai ir jų panaudojimas farmaciniais metalų chelatoriais
EN - SUBSTITUTED 3,5-DIPHENYL-1,2,4-TRIAZOLES AND THEIR USE AS PHARMACEUTICAL METAL CHELATORS
SPC
| (11) |
Number of the document |
C 0914118 |
| (68) |
Number of the document |
0914118
|
| (21) |
Application number for Supplementary Protection Certificate |
PA 2007 001 |
| (22) |
Date of filing the application |
2007-01-16 |
| (41) |
Date of publication of the application |
2007-03-26 |
|
Date of publication of SPC |
2007-09-25 |
| (24) |
Date of coming into effect of SPC |
2017-06-25 |
Applicant
| (71) |
Novartis AG,
Schwarzwaldallee 215, 4058 Basel,
CH
|
Grantee
| (73) |
Novartis AG ,
Lichtstrasse 35, 4056 Basel ,
CH
|
Attorney or representative
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
Number, date and code of the country of origin of the first authorization to place the medicinal or plant protection product on the market within regional economic community
| (93) |
EU/1/06/356/001 2006-08-28, EU/1/06/356/002 2006-08-28, EU/1/06/356/003 2006-08-28, EU/1/06/356/004 2006-08-28, EU/1/06/356/005 2006-08-28, EU/1/06/356/006, 2006-08-28
|
Calculated date of expiry of the SPC
| (94) |
2021-08-31 |
Name of the product protected by the basic patent
| (95) |
Deferasiroxum |
Paediatric extension
|
Request filed |
SPC extension granted until |
Request refused |
|
2018-06-05 |
2022-02-28 |
|
Last renewal fee
|
Payment date |
Validity (years) |
Amount |
|
2021-05-27 |
|
347.00
EUR
|
